Optimum blood collection intervals for B-type natriuretic peptide testing in patients with heart failure
- 1 June 2004
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 93 (12), 1562-1563
- https://doi.org/10.1016/j.amjcard.2004.02.072
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Biological variation of the natriuretic peptides and their role in monitoring patients with heart failureEuropean Journal of Heart Failure, 2004
- Clinical applications of B-type natriuretic peptide (BNP) testingEuropean Heart Journal, 2003
- Biological variation for N-Terminal Pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failureThe American Journal of Cardiology, 2003
- BNP test utilization for CHF in community hospital practice.Clinica Chimica Acta; International Journal of Clinical Chemistry, 2002
- Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failureThe American Journal of Cardiology, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapyAmerican Heart Journal, 1999
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997